Search

everythinglearnresearchcommunity

for

Search:↓

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Alefacept does not effectively treat severe alopecia areata.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Using Calcipotriol with Clobetasol is more effective for treating Alopecia Areata than using Clobetasol alone.

People with alopecia areata have much lower Vitamin-D levels than healthy individuals.

Intralesional vitamin D is mildly effective for treating Alopecia Areata.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Higher CRBP1 levels are linked to more severe alopecia areata.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Achieving 80% or more scalp hair regrowth is considered a successful treatment for significant hair loss.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.